exposed to S. aureus (Translational Genomics). After performing DNA testing, the Translational Genomics Research Institute discovered that the major source of S. aureus originated from food animals injected with antibiotics. “52 percent” of the S. aureus in meat and poultry were “resistant to three classes of antibiotics” (Translational Genomics). To resolve the problem, scientists’ must pinpoint the “effect antibiotics have in food-animal production” (Translational Genomics). Additionally,
the highest level of neurosurgical care, the division’ surgeons advance neurosurgery knowledge and practice through research and innovation. Below is a synopsis of the Neurosurgery division‘s research area of interest, activities, contributions and future goals/direction. A) Research areas of interest The Research interests of the Division of Neurosurgery are in translational, clinical trials, new technology and performance indicators as they pertain to spine, spinal cord injury, epilepsy
Health Science Research PD/PI Name: Ja’Terra Robinson Affiliation/Institution: Florida State College at Jacksonville Request for Proposal (RFP) from the National Institute of Health (NIH)-Choose One Pharmacokinetic and Pharmacodynamic Studies for Medications Development Transmission of Human Immunodeficiency Virus (HIV) In Semen Getting from Genes to Function in Lung Disease. X Developmental Mechanisms of Human Structural Birth Defects Eunice Kennedy Shriver National Institute of Child Health
resources landscape. Industry reports (IBISWorld) indicate that the oil and gas industries (e.g., gas extraction, gas field services, natural gas distribution) in Canada are expected to generate revenues of over $56.4bn in 2015. The Canadian Energy Research Institute projects Western Canada’s natural gas sector to add $2.3tn to Canada’s GDP between 2015 and 2035. While, sales are projected to generate $1.4tn in sales and $400bn in taxes, as well as attract over $450bn in capital investments over the next
Spring 2013: John C. Lincoln Desert Mission Food Bank During the time I spent volunteering at John C. Lincoln’s Food Bank, I was able to provide food, individual hygiene items, and infant supplies to families struggling to obtain these critical items for their families. When I first arrived at the food bank, I spent time constructing care packages with soap, toothbrushes, personal wipes, and other essential items for health care. Later in the day, I had the unique opportunity to assist with the
Biotechnological solutions to a variety of illnesses, surgical procedures, genetic exploits and a myriad of other things are now in the form of nanotechnology. Big pharmaceutical companies now refer to many of their medications, in fact, as nanomedicines, which alludes to the nanotechnological inputs in pills that improve delivery methods and even deploy nanoparticles for specific purposes on occasion. A new study actually illustrates how attaching RNA nanoparticles that masquerade as antibodies
dreads facing neuroscientists and modern day economists is that the US population is aging. Aging brings forth a tidal wave of neurodegenerative disease and the financial burden of more than $100 billion yearly (“Society for Neuroscience” 1). Clinical research and medicine has gone so far over the centuries that the human life expectancy has just about tripled. But there is always a catch.
Exploring various research opportunities on campus and summer internships have allowed me to shape what I want my future to look like. When the time approached to set my personal and professional goals, I made a conscientious decision to enter a field that would allow me to leave a positive impact on mankind, while adding to the current body of research. There is more that can be done by combining research and medicine, and additional steps I can take to enhance
sparked a controversy. In the 1980s, the Human Genome Project was formulated to sequence the entirety of the human genome. The first draft of this project was published in Nature in February, 2001, about 10 percent short of completion (National Institutes of Health [NIH], 2015). Originally, scientists had hypothesized that there was anywhere from 50,000 to 140,000 genes, but after the release of this first draft and the later completion of the full sequence in April 2003, it was revealed that there
informed about their genetic risks”, and “can make informed decisions about their hereditary risks” (“Cigna Builds”). Additionally, there are genetic testing companies that offer the help of a genetic counselor, included with the test itself. Color Genomics, which offers breast and ovarian cancer testing includes complementary genetic counseling. In March 2016, Veritas Genetics announced the launch of myGenome, which provides whole-genome sequencing for $999. This was a major breakthrough in the area